Intel Capital first partnered with Canada-based Smart Technologies in 1992 and the interactive education products company is planning to list in North America.
Category: Firms
Cisco commits $1bn to Russian ventures
Russia’s Skolkovo Project, its equivalent of America’s Silicon Valley, gains $1bn backing from Cisco to find new deals and help entrepreneurs.
NeuroSky taps Taicom Capital for C round
Asian strategic investors emerge to help US-based developer of biosensors for computer games and other electronic products NeuroSky.
Zhejiang Haiyue takes minority stake in Zn Animation
Zhejiang Tianyue Venture Capital, which is 100% owned by Haiyue, said it would invest RMB27.3m ($4m) for a 4.55% stake in Zn Animation.
Lowe’s backs second round for Recurve
Energy efficiency software supplier Recurve gains $8m in second round from home retailer Lowe’s Companies and VCs.
Roche and Astellas back Nereus Pharmaceuticals
Eight venture investors commit another $20m to Nereus a decade after its first round to take the total raised so far to nearly $150m.
Steamboat sails into Playdom
Disney’s corporate venturing division Steamboat Ventures backs $33m series A extension for social gaming company.
Vodafone makes Perfecto call
Israel-based Perfecto Mobile gains undisclosed funding from Vodafone Ventures.
Google and Reed Elsevier aid Rocket Lawyer
US-based legal information website Rocket Lawyer takes off with $7m C round.
Baxano takes care of $30m C round
CMEA Capital and Kaiser Permanente Ventures join $30m funding for Baxano
Incline finds right pitch for Cadence
Incline therapeutics acquires Ionsys assets to tempt Cadence into minority shareholding and option deal worth up to $290m.
Mavenir delivers fourth funding round
US-based mobile device software company Mavenir Systems gains fourth round of funding.
Oklahoma Publishing makes Inform link
US-based software company Inform Technologies raises $4m.
Arginetix and Immune Control merge
Investors including MedImmune Ventures, push through merger of biotech portfolio companies to form Corridor Pharmaceuticals.